A novel synonymous variant in exon 1 of

GNAS IPPSD2 PHP1A PPHP Pseudohypoparathyroidism Synonymous

Journal

Bone reports
ISSN: 2352-1872
Titre abrégé: Bone Rep
Pays: United States
ID NLM: 101646176

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 15 02 2021
revised: 17 04 2021
accepted: 20 04 2021
entrez: 17 5 2021
pubmed: 18 5 2021
medline: 18 5 2021
Statut: epublish

Résumé

Pseudohypoparathyroidism type 1A (PHP1A) and pseudopseudohypoparathyroidism (PPHP) (Inactivating PTH/PTHrP Signaling Disorders type 2, IPPSD2) are two rare autosomal disorders caused by loss-of-function mutations on either maternal or paternal allele, respectively, in the imprinted We investigated a synonymous

Identifiants

pubmed: 33997150
doi: 10.1016/j.bonr.2021.101073
pii: S2352-1872(21)00328-4
pmc: PMC8100090
doi:

Types de publication

Case Reports

Langues

eng

Pagination

101073

Informations de copyright

© 2021 Centre Hospitalier Universitaire de Caen. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Genet Test Mol Biomarkers. 2009 Dec;13(6):751-60
pubmed: 20001581
Trends Genet. 2014 Jul;30(7):308-21
pubmed: 24954581
Adv Bioinformatics. 2016;2016:5614058
pubmed: 27313609
J Clin Endocrinol Metab. 2002 Oct;87(10):4736-40
pubmed: 12364467
Endocr Rev. 2001 Oct;22(5):675-705
pubmed: 11588148
Horm Metab Res. 2015 Jul;47(8):585-90
pubmed: 25502941
J Clin Endocrinol Metab. 2013 Sep;98(9):E1549-56
pubmed: 23884777
J Bone Miner Res. 2020 May;35(5):913-919
pubmed: 31886927
PLoS One. 2014 Mar 20;9(3):e90640
pubmed: 24651309
Eur J Endocrinol. 2016 Dec;175(6):P1-P17
pubmed: 27401862
Nat Rev Genet. 2011 Aug 31;12(10):683-91
pubmed: 21878961
Ann Endocrinol (Paris). 2015 May;76(2):105-9
pubmed: 25952723
Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):10038-43
pubmed: 9707596
J Bone Miner Res. 2011 Oct;26(10):2473-85
pubmed: 21713996
Nat Genet. 2008 Oct;40(10):1245-52
pubmed: 18776912
Hum Mutat. 2015 Jan;36(1):11-9
pubmed: 25219572
Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8715-20
pubmed: 9671744
Clin Pediatr Endocrinol. 2011 Jan;20(1):21-3
pubmed: 23926390
Mol Genet Genomic Med. 2015 Mar;3(2):111-20
pubmed: 25802881
Genet Med. 2020 Jun;22(6):1005-1014
pubmed: 32123317

Auteurs

Andreea Apetrei (A)

Normandy University, UNICAEN, Caen University Hospital, Department of Genetics, Reference Center of Rare Diseases of Calcium and Phosphorus Metabolism, EA 7450 BioTARGen, Caen, France.

Arnaud Molin (A)

Normandy University, UNICAEN, Caen University Hospital, Department of Genetics, Reference Center of Rare Diseases of Calcium and Phosphorus Metabolism, EA 7450 BioTARGen, Caen, France.

Nicolas Gruchy (N)

Normandy University, UNICAEN, Caen University Hospital, Department of Genetics, Reference Center of Rare Diseases of Calcium and Phosphorus Metabolism, EA 7450 BioTARGen, Caen, France.

Manon Godin (M)

Normandy University, UNICAEN, Caen University Hospital, Department of Genetics, Reference Center of Rare Diseases of Calcium and Phosphorus Metabolism, EA 7450 BioTARGen, Caen, France.

Claire Bracquemart (C)

Normandy University, UNICAEN, Caen University Hospital, Department of Genetics, Reference Center of Rare Diseases of Calcium and Phosphorus Metabolism, EA 7450 BioTARGen, Caen, France.

Antoine Resbeut (A)

Normandy University, UNICAEN, Caen University Hospital, Department of Genetics, Reference Center of Rare Diseases of Calcium and Phosphorus Metabolism, EA 7450 BioTARGen, Caen, France.

Gaëlle Rey (G)

Metropole Savoie Hospital Center, Genetics Department, Chambéry, France.

Gwenaël Nadeau (G)

Metropole Savoie Hospital Center, Genetics Department, Chambéry, France.

Nicolas Richard (N)

Normandy University, UNICAEN, Caen University Hospital, Department of Genetics, Reference Center of Rare Diseases of Calcium and Phosphorus Metabolism, EA 7450 BioTARGen, Caen, France.

Classifications MeSH